4,188
Views
34
CrossRef citations to date
0
Altmetric
Research Article

The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison

ORCID Icon, , , , , , , , ORCID Icon, , , , , , & ORCID Icon show all
Pages 569-575 | Received 24 Jan 2017, Accepted 20 Jun 2017, Published online: 18 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Reshma Punjani, Theodore C. Larson, Laurie Wagner, Bryn Davis, D. Kevin Horton & Wendy Kaye. (2023) Survival and epidemiology of amyotrophic lateral sclerosis (ALS) cases in the Chicago and Detroit metropolitan cohort: incident cases 2009–2011 and survival through 2018. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 203-211.
Read now
Elisa Bianchi, Elisabetta Pupillo, Antonio De Feudis, Gabriele Enia, Eugenio Vitelli & Ettore Beghi. (2022) Trends in survival of ALS from a population-based registry. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 344-352.
Read now
Hikari Ando, Rosanna Cousins & Carolyn A. Young. (2022) Flexibility to manage and enhance quality of life among people with motor neurone disease. Disability and Rehabilitation 44:12, pages 2752-2762.
Read now
Jaime Luna, Jeremy Jost, Mouhamadou Diagana, Leila Ait Aissa, Meriem Tazir, Lamia Ali Pacha, Imen Kacem, Riadh Gouider, Franclo Henning, Anna Basse, Ousmane Cisse, AA Koffi Balogou, Damelan Kombate, Mendinatou Agbetou, Dismand Houinato, Dieu Donné Gnonlonfoun, Athanase Millogo, Thierry Agba, Mouftao Belo, Noudy Sengxeu, Bello Hamidou, Pierre-Marie Preux, Marin Benoit & Philippe Couratier. (2022) Clinical management and disease-modifying treatment for amyotrophic lateral sclerosis in African hospital centers: the TROPALS study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:3-4, pages 279-283.
Read now
Terry D. Heiman-Patterson, Ossama Khazaal, Daohai Yu, Michael E. Sherman, Edward J. Kasarskis & Carlayne E. Jackson. (2021) Pulmonary function decline in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:sup1, pages 54-61.
Read now
Pamela A. McCombe, Fleur C Garton, Matthew Katz, Naomi R Wray & Robert D Henderson. (2020) What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?. Expert Review of Neurotherapeutics 20:9, pages 921-941.
Read now
Polona Klavžar, Blaž Koritnik, Lea Leonardis, Leja Dolenc Grošelj, Mojca Kirbiš, Stanka Ristić Kovačič, Polona Klinar, Maja Pohar Perme & Janez Zidar. (2020) Improvements in the multidisciplinary care are beneficial for survival in amyotrophic lateral sclerosis (ALS): experience from a tertiary ALS center. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 203-208.
Read now
Reshma Punjani, Laurie Wagner, Kevin Horton & Wendy Kaye. (2020) Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009–2011 and survival characteristics through 2015. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 123-130.
Read now
Elizabeth Elliott, Judith Newton, Phillipa Rewaj, Jenna M. Gregory, Lynda Tomarelli, Shuna Colville, Siddharthan Chandran & Suvankar Pal. (2020) An epidemiological profile of dysarthria incidence and assistive technology use in the living population of people with MND in Scotland. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 116-122.
Read now

Articles from other publishers (25)

Kelly Gwathmey & Terry D. Heiman-Patterson. (2023) Multidisciplinary Clinics in Neuromuscular Medicine. CONTINUUM: Lifelong Learning in Neurology 29:5, pages 1585-1594.
Crossref
Fiona Runacres, Susan Mathers, Sarah CM Lee, Rowan Hearn, Sonia Gregory, Natasha Bear & Samar Aoun. (2023) Motor neurone disease: A point-prevalence study of patient reported symptom prevalence, severity and palliative care needs. Palliative Medicine.
Crossref
Carolina Parra-Cantu, Jennifer M. Martinez-Thompson, Forrest B. Linch, Tasha L. Welch, Claudia Z. Chou, Adele K. Pattinson, Nathan P. Staff & Melissa Neisen. (2023) Radiologically Inserted Gastrostomy Tube Placement Guided by the Assessment and Primary Palliative Care Provided by an Amyotrophic Lateral Sclerosis Multidisciplinary Clinic: A Single-Arm Retrospective Clinical Study. American Journal of Hospice and Palliative Medicine®, pages 104990912311805.
Crossref
Christopher H Grossman, Rowan Hearn, Maryanne McPhee, Fiona Fisher, Christine Wools & Susan Mathers. (2023) Neuropalliative care for progressive neurological diseases: A scoping review on models of care and priorities for future research. Palliative Medicine, pages 026921632311756.
Crossref
Christen Shoesmith. 2023. Neuropalliative Care, Part II. Neuropalliative Care, Part II 139 155 .
J. Luna, O. Defressigne, D. Erazo, G. Lautrette, M. Raymondeau-Moustafa, P.-M. Preux, F. Boumediene & P. Couratier. (2022) Epidemiological time-trend of amyotrophic lateral sclerosis (ALS) over two decades: The French population-based register of ALS in Limousin (FRALim register). Revue Neurologique 178:9, pages 914-923.
Crossref
Hugo M. De Oliveira, Matthew Silsby, Stephan R. Jaiser, H. Ming Lai, Nathan Pavey, Matthew C. Kiernan, Tim L. Williams, Steve Vucic & Mark R. Baker. (2022) Electrodiagnostic findings in facial onset sensory motor neuronopathy (FOSMN). Clinical Neurophysiology 140, pages 228-238.
Crossref
Jean-Paul Janssens. (2022) Amyotrophic lateral sclerosis: A pragmatic update on recommendations for respiratory care. Respiratory Medicine and Research 81, pages 100915.
Crossref
Morgan HardyCaitlin CastleCarlayne Jackson. (2022) Embedded Psychiatric Services in a Multidisciplinary Amyotrophic Lateral Sclerosis Clinic: An Assessment of Patient Needs and Perceptions. The Journal of Neuropsychiatry and Clinical Neurosciences 34:1, pages 53-59.
Crossref
Emilia Castro-Rodríguez, Rafael Azagra, Xavier Gómez-Batiste & Mónica Povedano. (2021) La esclerosis lateral amiotrófica (ELA) desde la Atención Primaria. Epidemiología y características clínico-asistenciales. Atención Primaria 53:10, pages 102158.
Crossref
Chun Seng Phua, Aloysius Ng, Christopher Brooks, Zinta Harrington, Hima Vedam, Thang Huynh, Desi Seccombe, Patrick Aouad & Dennis Cordato. (2021) Prevalence and factors associated with advanced care directives in a motor neuron disease multidisciplinary clinic in Australia. Postgraduate Medical Journal 97:1151, pages 566-570.
Crossref
Cristina Salvioni, Adriana Leico Oda, Marco Orsini, Michele Pauli, Luciana M. Frabasile, Percilia C. L. Alves, Rosana M. Borges, Helena N. M. Sierra, Gabriela Menegatti, Márcio Ottoboni Pinho & Acary Souza Bulle Oliveira. (2021) Association between Body Composition and Dysphagia in Patients with Amyotrophic Lateral Sclerosis. Neurology International 13:3, pages 315-327.
Crossref
Eva Eljas Ahlberg & Bertil Axelsson. (2020) End‐of‐life care in amyotrophic lateral sclerosis: A comparative registry study. Acta Neurologica Scandinavica 143:5, pages 481-488.
Crossref
Filipe Emanuel Oliveira de Almeida, Anne Kelly do Carmo Santana & Fernanda Oliveira de Carvalho. (2021) Multidisciplinary care in Amyotrophic Lateral Sclerosis: a systematic review and meta-analysis. Neurological Sciences 42:3, pages 911-923.
Crossref
Martin R Turner & Kevin Talbot. (2020) Primary lateral sclerosis: diagnosis and management. Practical Neurology 20:4, pages 262-269.
Crossref
James Grogan & Zachary Simmons. (2020) Telemedicine for the Care of Neuromuscular Disorders. Current Treatment Options in Neurology 22:6.
Crossref
Elizabeth Elliott, Olivia Bailey, Fergal M. Waldron, Giles E. Hardingham, Siddharthan Chandran & Jenna M. Gregory. (2020) Therapeutic Targeting of Proteostasis in Amyotrophic Lateral Sclerosis—a Systematic Review and Meta-Analysis of Preclinical Research. Frontiers in Neuroscience 14.
Crossref
Ammar Al-ChalabiLeo M. A. HeunksZoltán Papp & Piero Pollesello. (2019) Potential of the Cardiovascular Drug Levosimendan in the Management of Amyotrophic Lateral Sclerosis: An Overview of a Working Hypothesis. Journal of Cardiovascular Pharmacology 74:5, pages 389-399.
Crossref
Esther Hobson, Wendy Baird, Mike Bradburn, Cindy Cooper, Susan Mawson, Ann Quinn, Pamela J Shaw, Theresa Walsh & Christopher J McDermott. (2019) Process evaluation and exploration of telehealth in motor neuron disease in a UK specialist centre. BMJ Open 9:10, pages e028526.
Crossref
Esther V Hobson, Wendy O Baird, Mike Bradburn, Cindy Cooper, Susan Mawson, Ann Quinn, Pamela J Shaw, Theresa Walsh & Christopher J McDermott. (2019) Using telehealth in motor neuron disease to increase access to specialist multidisciplinary care: a UK-based pilot and feasibility study. BMJ Open 9:10, pages e028525.
Crossref
Christopher T. DoughtyAmanda C. GuidonSabrina PaganoniE. Tessa Hedley-Whyte. (2019) Case 12-2019: A 60-Year-Old Man with Weakness and Difficulty Chewing. New England Journal of Medicine 380:16, pages 1566-1574.
Crossref
Chiara F. Valori, Giulia Guidotti, Liliana Brambilla & Daniela Rossi. 2019. Neuroglia in Neurodegenerative Diseases. Neuroglia in Neurodegenerative Diseases 227 272 .
Katharina Linse, Elisa Aust, Markus Joos & Andreas Hermann. (2018) Communication Matters—Pitfalls and Promise of Hightech Communication Devices in Palliative Care of Severely Physically Disabled Patients With Amyotrophic Lateral Sclerosis. Frontiers in Neurology 9.
Crossref
Paul Mehta, D. Kevin Horton, Edward J. Kasarskis, Ed Tessaro, M. Shira Eisenberg, Susan Laird & John Iskander. (2017) CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions. MMWR. Morbidity and Mortality Weekly Report 66:50, pages 1379-1382.
Crossref
Andrew P. Tosolini & James N. Sleigh. (2017) Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 10.
Crossref